Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Growth Metrics

Trulieve Cannabis (TCNNF) Amortization of Goodwill (2023)

Trulieve Cannabis has reported Amortization of Goodwill over the past 1 years, most recently at $307.6 million for Q2 2023.

For Q2 2023, Amortization of Goodwill changed N/A year-over-year to $307.6 million; the TTM value through Jun 2024 reached $307.6 million, changed 0.0%, while the annual FY2023 figure was $307.6 million, N/A changed from the prior year.
Amortization of Goodwill for Q2 2023 was $307.6 million at Trulieve Cannabis.
Over five years, Amortization of Goodwill peaked at $307.6 million in Q2 2023 and troughed at $307.6 million in Q2 2023.